Media
News
Are you a media representative looking for content on Bayer? This section provides access to media releases as well as feeds from our social media channels.
33 - 37of about 37 News
33 - 37of about 37 News
Bayer Inc. investing $500,000 in STEM education for Canadian youth through Let’s Talk Science
Bayer’s darolutamide plus androgen deprivation therapy (ADT) significantly extends metastasis-free survival by 22 months, with a favourable safety profile compared to placebo plus ADT in non-metastatic castration-resistant prostate cancer